Northern Trust Corp Brooklyn Immuno Therapeutics, Inc. Transaction History

Northern Trust Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.48 - $2.03 $96,777 - $409,288	-201,620 Reduced 80.4%	49,148 $25,000
Q1 2022 May 13, 2022	SELL	$1.76 - $4.84 $29,363 - $80,750	-16,684 Reduced 6.24%	250,768 $514,000
Q4 2021 Feb 08, 2022	BUY	$4.17 - $9.79 $25,962 - $60,952	6,226 Added 2.38%	267,452 $1.12 Million
Q3 2021 Nov 15, 2021	BUY	$8.86 - $17.05 $271,975 - $523,383	30,697 Added 13.32%	261,226 $2.43 Million
Q2 2021 Aug 13, 2021	BUY	$3.75 - $78.5 $864,483 - $18.1 Million	230,529 New	230,529 $4.15 Million

1.21M

Ticker BTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,825,700
Description
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.